» Articles » PMID: 33282166

Haematological Abnormalities and Risk of COVID-19 Infection in Adult Patients Attending Primary Healthcare Settings

Overview
Journal Hematol Rep
Publisher MDPI
Date 2020 Dec 7
PMID 33282166
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Centres for Disease Control and prevention (CDC) reports that there are limited data and information about the impact of underlying medical conditions and the risk of infection. To date, there are no studies that report on the risk of infection among patients with haematological diseases or abnormalities. This cross-sectional study reports on the baseline complete blood count in patients attending publicly funded primary care settings with a diagnosis of suspected COVID-19 infections in the state of Qatar. The study will report on the descriptive characteristics of the population, including gender, age and prior abnormalities to their blood test results. We will compare the results of those with positive and negative PCR test results, where appropriate. Nine hundred sixty-two adult patients attended publicly funded primary health care settings in the state of Qatar between February the 10th and April the 30th 2020 with a diagnosis of suspected COVID-19 infections had prior recorded blood investigations in the last six months and were included in this study. The population was young, mean of age is 38.8±11.6. (Median: 36 [Min: 19 - Max: 85]). Complete blood count of the sample had minimal missing data points. Females were more presented in our samples, Female (n=560, 58.21%) and Male (n=402, 41.79%). Most of our sample had a documented PCR test result, negative (n=831, 86.38%); positive (n=123, 12.79%) and missing (n=8, 0.83%). Low haemoglobin values (n=265, 27.5%) and low red blood cell count (n =170, 17.7%) were the most prevalent complete blood count abnormality in the population. Leukopenia was less common (n=50, 8.2%). Most of the population had normal platelet count (n=895, 93%). Gender was the most influential factor in our sample to increase the odds of having a positive PCR test results; males were more likely to be affected (P<0.001, Chi-square test) (OR 2.56, 95% CI 1.73-3.77). Categories for haematological abnormalities were not associated with increased risk of having a positive PCT test result. In a population attending primary healthcare settings with early presentation of symptoms of COVID-19 infection, the risk of infection among our cohort was not affected by the prior haematological values of those patients. Gender was the most influential parameter in the risk of infection in our population. Analysis of the results using gender-specific categories for different haematological parameters suggested that patients with abnormal haematological values were not at increased risk of having a positive COVID-19 infection.

Citing Articles

Individual risk factors associated with SARS-CoV-2 infection during Alpha variant in high-income countries: a systematic review and meta-analysis.

Moniz M, Pereira S, Soares P, Aguiar P, Donato H, Leite A Front Public Health. 2024; 12:1367480.

PMID: 39139667 PMC: 11319152. DOI: 10.3389/fpubh.2024.1367480.


Evaluation of circulating insulin-like growth factor-1, heart-type fatty acid-binding protein, and endotrophin levels as prognostic markers of COVID-19 infection severity.

Mohamed A, Nour A, Mosbah N, Wahba A, Esmail O, Eysa B Virol J. 2023; 20(1):94.

PMID: 37189123 PMC: 10183690. DOI: 10.1186/s12985-023-02057-4.


Hematological abnormalities in immunosuppressed patients with COVID-19: Evidence from a single center. A cross sectional study.

Giacaman A, Henriquez W, Tolosa G, Prado A, Jerez R, Reveco Y Int Immunopharmacol. 2022; 109:108862.

PMID: 35640406 PMC: 9110370. DOI: 10.1016/j.intimp.2022.108862.

References
1.
Gao Y, Chen Y, Liu M, Shi S, Tian J . Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis. J Infect. 2020; 81(2):e93-e95. PMC: 7228685. DOI: 10.1016/j.jinf.2020.05.017. View

2.
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis T, Politou M . Hematological findings and complications of COVID-19. Am J Hematol. 2020; 95(7):834-847. PMC: 7262337. DOI: 10.1002/ajh.25829. View

3.
Ramakrishnan M, Moisi J, Klugman K, Iglesias J, Grant L, Mpoudi-Etame M . Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. Lancet Infect Dis. 2010; 10(5):329-37. DOI: 10.1016/S1473-3099(10)70055-4. View

4.
McCloskey K, Meenan J, Hall R, Tsitsikas D . COVID-19 infection and sickle cell disease: a UK centre experience. Br J Haematol. 2020; 190(2):e57-e58. DOI: 10.1111/bjh.16779. View

5.
Harter G, Spinner C, Roider J, Bickel M, Krznaric I, Grunwald S . COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection. 2020; 48(5):681-686. PMC: 7211976. DOI: 10.1007/s15010-020-01438-z. View